STEMCYTE
Live / Registered — Registered and renewed (as of 28 Mar 2018)
What this means for you
Registered since 29 Apr 2008. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 29 Apr 2018).
Record
- Serial number
- 77040554
- Registration number
- 3416684
- Mark type
- Stylized text
- Filed
- 09 Nov 2006
- Published for opposition
- 12 Feb 2008
- Registered
- 29 Apr 2008
- Next maintenance due
- 29 Apr 2018
- Attorney of record
- R. Gwen Peterson
Goods and services
- Class 001 — Chemicals: Human tissues for stem cell research, namely, umbilical cord blood, components of umbilical cord blood, stem cells and plasma depleted umbilical cord blood compositions
- Class 005 — Pharmaceuticals: Human tissues for stem cell transplantation and medical therapy, namely, umbilical cord blood, components of umbilical cord blood, stem cells and plasma depleted umbilical cord blood compositions
Owner
- StemCyte, Inc., Baldwin Park, CA, US
- StemCyte, Inc., Arcadia, CA, US
- StemCyte, Inc., Arcadia, CA, US
Prior registrations
Prosecution history
- 28 Mar 2018 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 28 Mar 2018 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 28 Mar 2018 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 28 Mar 2018 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 14 Mar 2018 — TEAS SECTION 8 & 9 RECEIVED
- 29 Apr 2017 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 06 May 2016 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 06 May 2016 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 05 May 2016 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 05 May 2016 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 16 May 2014 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 16 May 2014 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 29 Apr 2014 — REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
- 16 May 2014 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 29 Apr 2014 — TEAS SECTION 8 & 15 RECEIVED